Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7618224 | 0.86 | HDAC1 (0.45) | KMT2AKCNH2HDAC1HDAC6KDM4E | |
| SCHEMBL7620197 | 0.86 | DRD1 (0.45) | KMT2AHDAC1HDAC6KDM4EMEN1 | |
| SCHEMBL7617252 | 0.82 | F10 (0.45) | MAOBHDAC1HDAC6KDM4ELMNA | |
| Hydrochloric Acid SCHEMBL5755808 | 0.75 | CA1 (0.44) | MAOBKMT2AABCB1MEN1 | |
| SCHEMBL7619422 | 0.73 | LMNA (0.48) | KMT2AKDM4ERAB9AMEN1LMNA | |
| SCHEMBL11452302 | 0.73 | ALDH1A1 (0.43) | KMT2AHDAC1HDAC6KDM4EMEN1 | |
| SCHEMBL22048862 | 0.72 | MAOA (0.47) | MAOBKMT2AABCB1HDAC1HDAC6 | |
| SCHEMBL27586486 | 0.72 | MAOB (0.41) | MAOBKMT2AABCB1HDAC1HDAC6 | |
| SCHEMBL5755108 | 0.70 | MAPT (0.54) | KMT2AABCB1RAB9AMEN1LMNA | |
| SCHEMBL7625300 | 0.69 | F10 (0.48) | KMT2AHDAC1HDAC6KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020019389-A1 | Urea derivative useful as an anti-cancer agent and process for preparing same | CHACONNE NSI CO., LTD. (KR) | 2002-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020019389-A1 | Urea derivative useful as an anti-cancer agent and process for preparing same | UTS2R, SLC14A1, URB2 | MAOB 1452/4885KMT2A 1908/4885ABCB1 1802/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.